Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-468

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 25021-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Lev1y 0000 01)

Figure (Lev1y 0000 01)
Chemical structure of Levothyroxine Sodium Anhydrous, the active ingredient in Levothyroxine Sodium injection, powder, lyophilized, for solution for intravenous use by Sagent Pharmaceuticals.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Lev1y 0000 02)

Package Label – Principal Display Panel – Vial Label (Lev1y 0000 02)
Label for Levothyroxine Sodium for Injection 100 mcg per vial, lyophilized powder for intravenous injection. It is a single-dose vial, sterile and preservative-free, intended for intravenous use. The label indicates storage instructions, directions for reconstitution, and manufacturer details for Sagent Pharmaceuticals, Schaumburg, IL, USA, with the product made in India.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Lev1y 0000 03)

Package Label – Principal Display Panel – Vial Label (Lev1y 0000 03)
Label for Levothyroxine Sodium Injection, 200 mcg per vial, a single-dose vial for intravenous use. This lyophilized powder is sterile, nonpyrogenic, and preservative-free. The label includes usage directions, storage instructions, NDC 25021-469-10, and manufacturing details by Sagent Pharmaceuticals, made in India.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Lev1y 0000 04)

Package Label – Principal Display Panel – Vial Label (Lev1y 0000 04)
Label for Levothyroxine Sodium for Injection, 500 mcg per vial, an intravenous injection powder, lyophilized, for solution. The label states it is a single-dose vial, sterile, preservative-free, and nonpyrogenic. It includes dosing and handling instructions and is manufactured for Sagent Pharmaceuticals. The label also shows NDC 25021-470-10 and indicates product origin as India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.